Global Clinical Trials Packaging Market - Strategic Insights and Forecasts (2025-2030)
Description
Clinical Trials Packaging Market Size:
The Global Clinical Trials Packaging Market is expected to grow from USD 2.740 billion in 2025 to USD 4.139 billion in 2030, at a CAGR of 8.60%.
Clinical Trials Packaging Market Key Highlights:
- Researchers are conducting more clinical trials globally due to rising rare diseases.
- Market players are enhancing packaging quality for sensitive drugs and temperature control.
- Demand is increasing for stringent primary and secondary packaging across trial phases.
- North America is dominating with stringent regulations and growing pharmaceutical investments.
Clinical Trials Packaging Market Trends:
As there has been an increase in the number of orphan diseases or rare diseases affecting the population throughout the world, there has been a surge in the number of clinical trials being carried out worldwide. According to the statistics by the U.S. National Library OF Medicine, there are about 165,436 or 49% of the clinal studies and research being conducted in non-U.S. locations, 112,905 or 34% have been conducted in the U.S only, and 17,369 or 5% have been conducted in both U.S. and Non-U.S. locations. Lastly, the data for 39,492, or 12% of clinical trials in other locations, has not been reported. This calls for medicine and pharmaceutical manufacturers to come up with better formulations and competent compositions to control these diseases effectively. Consequently, it is putting a burden on the clinical trial packing companies and players to improve the state and the quality of their packing solutions as there is a critical issue involved in the packaging of sensitive drugs for clinical trials.
To learn more about this report, request a free sample copy
In addition, there are 4 phases in clinical trials, Phase I – Phase IV. Each phase requires a stringent packaging requirement. In Phase 1, only a limited number of packs are sent, so packaging called the primary packaging must be good enough as the shelf life of the testing medicine is not much. More importantly, typical secondary packaging contains adequate labelling, which should include the name of the producer, the name of the medication and all of its ingredients, as well as the shelf life of each, as well as any necessary precautions to prevent tampering and counterfeiting. Then the primary packaged medicine, which is done using the cold form or thermoforms techniques, is out inside the secondary package, such as bottles, kits, or others with effective temperature control. Therefore, this has led to an increase in the demand for effective packing solutions by the market players and is a major driving factor in the market growth over the forecast period.
Furthermore, the market is anticipated to expand throughout the forecast period as a result of the rising need for safe, environmentally friendly, and hygienic packaging choices for healthcare products and eCommerce shipping.
Clinical Trials Packaging Market Geographical Outlook:
- The North American region to hold a considerable share over the forecast period due to increasing initiatives taken by the organizations, stringent regulations, and increasing investments
The North American region is expected to hold a significant share over the forecast period, which is attributable to the fact that the pharmaceutical and packing industry in the US is flourishing due to the increasing influx of investments. In addition, there are stringent guidelines in place for the packaging of the medicine to be used for clinical trials by organizations such as the FDA that must be complied with by the market players to minimize their losses and avoid the imposition of heavy penalties.
Clinical Trials Packaging Market Scope:
| Report Metric | Details |
|---|---|
| Global Clinical Trials Packaging Market Size in 2025 | USD 2.740 billion |
| Global Clinical Trials Packaging Market Size in 2030 | USD 4.139 billion |
| Growth Rate | 8.60% |
| Study Period | 2020 to 2030 |
| Historical Data | 2020 to 2023 |
| Base Year | 2024 |
| Forecast Period | 2025 – 2030 |
| Forecast Unit (Value) | Billion |
| Segmentation | Product Type, Material Type, Packaging Type, Geography |
| Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| List of Major Companies in Global Clinical Trials Packaging Market |
|
| Customization Scope | Free report customization with purchase |
Clinical Trials Packaging Market Segmentation:
- By Product Type
- Vials
- Blisters
- Tubes
- Bottles
- Sachets
- Bags and Pouches
- Others
- By Material Type
- Plastic
- Glass
- Metal
- Paper & Paperboard
- Others
- By Packaging Type
- Primary Packaging
- Secondary Packaging
- Tertiary Packaging
- By Geography
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- UK
- Germany
- France
- Spain
- Others
- Middle East and Africa
- Saudi Arabia
- UAE
- Others
- Asia Pacific
- Japan
- China
- India
- South Korea
- Indonesia
- Taiwan
- Others
- North America
Frequently Asked Questions (FAQs)
The clinical trials packaging market is expected to reach a total market size of US$4.139 billion by 2030.
Clinical Trials Packaging Market is valued at US$2.740 billion in 2025.
The clinical trials packaging market is expected to grow at a CAGR of 8.60% during the forecast period.
The North American region holds a considerable share of the clinical trial packaging market due to increasing initiatives taken by the organizations, stringent regulations, and increasing investments.
The clinical trials packaging market is anticipated to expand as a result of the rising need for safe, environmentally friendly, and hygienic packaging choices for healthcare products and eCommerce shipping.
Table Of Contents
1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL CLINICAL TRIALS PACKAGING MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Vials
5.3. Blisters
5.4. Tubes
5.5. Bottles
5.6. Sachets
5.7. Bags and Pouches
5.8. Others
6. GLOBAL CLINICAL TRIALS PACKAGING MARKET BY MATERIAL TYPE
6.1. Introduction
6.2. Plastic
6.3. Glass
6.4. Metal
6.5. Paper & Paperboard
6.6. Others
7. GLOBAL CLINICAL TRIALS PACKAGING MARKET BY PACKAGING TYPE
7.1. Introduction
7.2. Primary Packaging
7.3. Secondary Packaging
7.4. Tertiary Packaging
8. GLOBAL CLINICAL TRIALS PACKAGING MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Product Type
8.2.2. By Material Type
8.2.3. By Packaging Type
8.2.4. By Country
8.2.4.1. USA
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Product Type
8.3.2. By Material Type
8.3.3. By Packaging Type
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Product Type
8.4.2. By Material Type
8.4.3. By Packaging Type
8.4.4. By Country
8.4.4.1. United Kingdom
8.4.4.2. Germany
8.4.4.3. France
8.4.4.4. Spain
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Product Type
8.5.2. By Material Type
8.5.3. By Packaging Type
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. UAE
8.5.4.3. Others
8.6. Asia Pacific
8.6.1. By Product Type
8.6.2. By Material Type
8.6.3. By Packaging Type
8.6.4. By Country
8.6.4.1. China
8.6.4.2. Japan
8.6.4.3. India
8.6.4.4. South Korea
8.6.4.5. Taiwan
8.6.4.6. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Piramal Pharma Solutions
10.2. Almac Group
10.3. Thermo Fisher Scientific Inc.
10.4. Clinigen Clinical Supplies Management
10.5. Xerimis
10.6. PCI Services
10.7. SGS SA (Quay Pharma)
10.8. Bilcare Ltd
10.9. Lonza
10.10. Mikart, LLC
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
Companies Profiled
Piramal Pharma Solutions
Almac Group
Thermo Fisher Scientific Inc.
Clinigen Clinical Supplies Management
Xerimis
PCI Services
SGS SA (Quay Pharma)
Bilcare Ltd
Lonza
Mikart, LLC
Related Reports
| Report Name | Published Month | Download Sample |
|---|---|---|
| Aseptic Packaging Market Report: Size, Share, Forecast 2030 | April 2025 | |
| Pharmaceutical Packaging Market Report: Share, Forecast 2030 | April 2025 | |
| Medical Devices Packaging Market Report: Share, Forecast 2030 | April 2025 | |
| South Korea Aseptic Packaging Market Size: Report, 2023 - 2028 | June 2023 | |
| Australia Aseptic Packaging Market Report 2030 | Industry Insights | May 2025 |